Form 4: Globus Medical Director Ann D. Rhoads Acquires 15,000 Stock Options

Director Ann D. Rhoads of Globus Medical Inc. (GMED) was granted 15,000 stock options on January 23, 2025, exercisable for Class A Common Stock.

Summary

• Ann D. Rhoads, a director of Globus Medical Inc. (GMED), filed a Form 4 indicating changes in beneficial ownership.
• On January 23, 2025, Rhoads was granted 15,000 stock options with an exercise price of $92.42.
• These options are for Class A Common Stock and will vest on January 1, 2026.
• The options expire on January 23, 2035.
• Following the transaction, Rhoads directly owns 15,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard executive compensation practice. The granting of options is generally viewed positively as it aligns interests, but it's not a major event.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders, potentially incentivizing them to work towards increasing the company's value.

Industry Context

Stock options are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Stakeholder Impact

• The granting of stock options can positively impact shareholders by aligning the director's interests with the company's long-term success.

Key Dates

Keywords

Form 4, Globus Medical, Stock Options, Beneficial Ownership, Director, GMED, Ann D. Rhoads